Alopecia Areata Market Report 2026

Alopecia Areata Market Overview

• Alopecia Areata market size has reached to $3.81 billion in 2025 • Expected to grow to $5.72 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Rising Incidence Sparks Growth In The Alopecia Areata Market • Market Trend: FDA Approval Marks A Milestone In Innovative Alopecia Areata Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Alopecia Areata Market?

Alopecia areata, also known as spot baldness, refers to an autoimmune disorder where the immune system targets hair follicles, resulting in hair loss and patchy bald spots on the scalp, each about the size of a coin. It is a non-scarring condition that can affect individuals of all ages and characterized by the sudden loss of hair in small, soft, hairless patches. The main types of alopecia areata are patchy alopecia areata, alopecia totalis, alopecia universalis, diffuse alopecia areata, ophiasis alopecia, and others. Patchy Alopecia Areata refers to a form of hair loss characterized by small circular patches on the scalp or other body areas. Various types of treatments are included, such as medical treatments, natural treatments, and others. It can be diagnosed through trichoscopy, skin biopsy, and other diagnostics. These treatments can be administered through various routes, such as oral, topical, parenteral, and others, which are used by several end-users, including hospitals, specialty clinics, homecare, and others.

What Is The Alopecia Areata Market Growth Forecast?

The alopecia areata market size is expected to see strong growth in the next few years. It will grow to $5.72 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to development of novel immunotherapy drugs, increasing investment in dermatology research, rising preference for personalized hair loss treatments, expansion of homecare and teledermatology services, growing clinical trials for hair regrowth. Major trends in the forecast period include increasing awareness about autoimmune hair disorders, rising adoption of topical and oral therapies, growth in specialized clinics and homecare solutions, advancements in trichoscopy and diagnostic techniques, increasing research in novel hair regrowth treatments.

Global Alopecia Areata Market Segmentation

1) By Type: Patchy Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Diffuse Alopecia Areata, Ophiasis Alopecia 2) By Diagnosis: Trichoscopy, Skin Biopsy, Other Diagnoses 3) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration 4) By End-Users: Hospitals, Specialty Clinics

What Is The Driver Of The Alopecia Areata Market?

Increasing incidence of alopecia is expected to propel the growth of the alopecia areata market going forward. Alopecia refers to the partial or complete loss of hair, usually from the scalp but potentially from other areas of the body as well. Increasing incidence of alopecia is primarily due to rising autoimmune disorders, heightened stress levels, genetic susceptibility, and environmental triggers that disrupt normal hair-follicle functioning. Alopecia areata treatments help address this growing burden by targeting immune-mediated follicular inflammation, promoting hair regrowth, and improving patient quality of life through more effective and faster-acting therapeutic options. For instance, in July 2023, according to an article published by the U.S. Department of Health and Human Services, more than 50 Mn men and 30 Mn women are estimated to be affected by androgenetic alopecia in U.S. each year. Therefore, the increasing incidence of alopecia is driving the growth of the alopecia areata industry.

Key Players In The Global Alopecia Areata Market

Major companies operating in the alopecia areata market are Pfizer Inc., Eli Lilly and Company, Incyte Corporation, AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb, GlaxoSmithKline plc, Aclaris Therapeutics Inc., Almirall SA, Lupin Ltd., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Dr Reddys Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals, Arena Pharmaceuticals, AnaptysBio Inc., Viela Bio, Priovant Therapeutics

Global Alopecia Areata Market Trends and Insights

Major companies operating in the alopecia areata market are focusing on innovative drug approvals, such as Janus kinase (JAK) inhibitors, to strengthen their market position and deliver next-generation therapies. JAK inhibitors are a class of medications that block specific enzymes (JAK1/JAK2) involved in the autoimmune process that attacks hair follicles, thereby promoting hair regrowth in patients with severe alopecia areata. For instance, June 2023, Pfizer Inc., a US-based biotechnology and pharmaceutical company, announced that the US Food and Drug Administration (FDA), a US-based federal agency of the Department of Health and Human Services responsible for protecting public health, had approved LITFULOTM (ritlecitinib), the first and only treatment for severe alopecia areata approved for patients as young as 12. It is a once-daily oral treatment for alopecia areata, an autoimmune condition for which there were previously no FDA-approved treatments for teenagers and few options for adults. LITFULO is a kinase inhibitor that blocks Janus kinase 3 (JAK3) and the tyrosine kinase family of kinases found in hepatocellular carcinoma (TEC).

What Are Latest Mergers And Acquisitions In The Alopecia Areata Market?

In March 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. The acquisition would broaden Sun Pharma's foothold in the Boston biotech cluster and add deuruxolitinib, a late-stage, potentially best-in-class therapy for alopecia areata, to its expanding worldwide dermatology portfolio. Concert Pharmaceuticals is a US-based late-stage clinical biopharmaceutical company that develops products for treating alopecia areata.

Regional Outlook

North America was the largest region in the alopecia areata market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Alopecia Areata Market?

The alopecia areata market consists of revenues earned by entities by providing combination therapy, topical immunotherapy, photochemotherapy, and aromatherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia areata market also includes sales of glucocorticoids, vasodilators, immunomodulators, and Janus kinase inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Alopecia Areata Market Report 2026?

The alopecia areata market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the alopecia areata industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.